GlassScriptPhysician profile
Mona N Sheth
NPI 1790816791
$9,992.34
in general payments reported to CMS, 2019-2025
48 companies · $1,790 in 2025
The $1,790 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $683 · 2021: $837 · 2022: $1,336 · 2023: $2,310 · 2024: $2,284 · 2025: $1,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,383.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,206.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $719.39 | 2019-2025 | Ubrelvy, Linzess, Viberzi |
| Lilly USA, LLC | $698.12 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $621.44 | 2023-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $600.47 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $571.38 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $458.33 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.75 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $340.03 | 2019-2025 | Gardasil 9, Capvaxive, Verquvo |
| Sanofi-Aventis U.S. LLC | $322.39 | 2019-2025 | |
| Dexcom, INC. | $280.11 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $260.31 | 2019-2025 | Repatha, Otezla, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $250.43 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $225.67 | 2019-2025 | Xifaxan, Trulance |
| Eisai INC. | $196.29 | 2020-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.